MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1688.68%
Quick Ratio
1688.68%
Cash Ratio
214.21%
Debt to Asset Ratio
18.48%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Operating lease right-of-use ass...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
22,190 45,445 93,732 86,820
Short-term investments
148,702 145,499 148,065 176,053
Prepaid expenses and other current assets (note 5)
3,132 4,464 3,791 4,571
Property and equipment held for sale (note 4)
906 1,040 NaN NaN
Total current assets
174,930 196,448 245,588 267,444
Property and equipment, net (note 4)
2,664 2,940 4,344 4,892
Operating lease right-of-use assets (note 15)
23,131 23,966 24,794 25,615
Restricted cash
1,482 1,482 1,482 1,482
Other non-current assets
389 392 392 391
Total assets
202,596 225,228 276,600 299,824
Accounts payable
362 480 485 1,384
Accrued research and development
4,141 4,804 7,779 10,790
Accrued liabilities (note 6)
4,143 9,634 8,173 7,192
Operating lease liabilities, current (note 15)
1,713 1,447 1,187 1,225
Total current liabilities
10,359 16,365 17,624 20,591
Operating lease liabilities, non-current (note 15)
27,071 27,658 28,231 28,791
Long-term debt (note 7)
0 0 30,439 30,360
Total liabilities
37,430 44,023 76,294 79,742
Common stock, 0.0001 par value per share 300,000,000 shares authorized at march 31, 2026 and december 31, 2025 and 61,914,569 and 61,449,290 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively (note 9)
6 6 6 6
Additional paid-in capital
1,044,937 1,040,610 1,036,085 1,029,595
Accumulated deficit
-879,436 -859,396 -835,819 -809,518
Accumulated other comprehensive loss
-341 -15 34 -1
Total stockholders equity
165,166 181,205 200,306 220,082
Total liabilities and stockholders equity
202,596 225,228 276,600 299,824
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$148,702K Cash and cashequivalents$22,190K Prepaid expenses andother current assets...$3,132K Property and equipmentheld for sale (note 4)$906K Total current assets$174,930K Operating leaseright-of-use assets (note 15)$23,131K Property and equipment,net (note 4)$2,664K Restricted cash$1,482K Other non-currentassets$389K Total assets$202,596K Total liabilities andstockholders equity$202,596K Total stockholdersequity$165,166K Total liabilities$37,430K Accumulated deficit-$879,436K Accumulated othercomprehensive loss-$341K Additional paid-in capital$1,044,937K Operating leaseliabilities, non-current...$27,071K Total currentliabilities$10,359K Common stock, 0.0001par value per share...$6K Accrued liabilities(note 6)$4,143K Accrued research anddevelopment$4,141K Operating leaseliabilities, current (note...$1,713K Accounts payable$362K

PLIANT THERAPEUTICS, INC. (PLRX)

PLIANT THERAPEUTICS, INC. (PLRX)